The Pharmacogenomics
Technology Market report discusses the
primary market growth drivers and challenges that the vendors and the market as
a whole face and provides an overview of the key trends emerging in the market.
It also talks about the market size of different segments and their growth
aspects along with key leading countries in Americas, Asia-Pacific, Europe, the
Middle East, and Africa regions.
Market
Slingshot:
The scope of
the global Pharmacogenomics Technology (Theranostics and Companion Diagnostics)
Market was appreciated by US$ 5.62 billion in 2016 and it is likely to reach
US$ 18.3 billion during the forecast period. This could be attributed to growth
in geriatric population, prevalence of chronic diseases like HIV, tuberculosis,
and cancer, increase in awareness amongst the patients regarding personalized
therapy, and adoption of pharmacogenomics by loads of healthcare professionals.
The
pharmacogenomics technology market is also likely to get bolstered
technological advancements related to molecular diagnostics. At the same time,
there is a dearth on the part of highly skilled and trained healthcare
professionals in conducting pharmacogenomics diagnostics tests. Besides,
emerging economies need to think twice before affirming pharmacogenomics tests
as initial as well as operating costs are high. Governments herein do struggle
with funding on this count.
Download Free Sample Report Now @ https://www.millioninsights.com/industry-reports/pharmacogenomics-technology-market/request-sample
Some of the
major objectives of this report:
1. To provide
detailed analysis of the market structure along with forecast of the various
segments and sub-segments of the global Pharmacogenomics Technology Market.
2. To provide
insights about factors affecting the market growth. To analyze the
Pharmacogenomics Technology Market based on various factors- price analysis,
supply chain analysis, porter five force analysis etc.
3. To provide
historical and forecast revenue of the Pharmacogenomics Technology Market
segments and sub-segments with respect to four main geographies and their
countries- North America, Europe, Asia, and Rest of the World.
4. Country
level analysis of the market with respect to the current market size and future
prospective.
5. To provide
country level analysis of the market for segment by application, product type
and sub-segments.
6. To provide
strategic profiling of key players in the market, comprehensively analyzing
their core competencies, and drawing a competitive landscape for the market.
7. Track and
analyze competitive developments such as joint ventures, strategic alliances,
mergers and acquisitions, new product developments, and research and
developments in the global Pharmacogenomics Technology Market.
Market
Segmentation:
The
pharmacogenomics theranostics market is segmented by application, technology,
end-user, and geography. By application, the segmentation goes like
cardiovascular disease, pain management, psychiatry, infectious diseases,
oncology, and neurological disease. By technology, the pharmacogenomics
technology industry spans sequencing, polymerase chain reaction, mass
spectrometry, microarray, and electrophoresis. By end-user, the
pharmacogenomics companion diagnostics (CDx) market states research
organizations & academic institutes and hospitals and clinics. By
geography, it comprises North America, Asia Pacific, LATAM, Europe, and MEA.
Regional
Insights:
North America
rules the roost; thanks to extensive investment in healthcare by the U.S.
Europe comes in second due to Belgium and Denmark being on the top pedestal
with respect to healthcare. Asia Pacific is expected to grow at the fastest
pace owing to increase in awareness among the economies like India and China
regarding healthcare. LATAM will also catch up due to presence of Brazil;
followed by MEA. In fact, MEA would be more vigilant on this count; due to the
figures released by WHO. It says that over 50% of the diseases mentioned above
occur in sub-Saharan Africa.
Players:
The players
contributing to the pharmacogenomics technology market include OPKO Health,
Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceutical Industries Ltd.,
Dynamic DNA Laboratories, Abbott Laboratories, F. Hoffmann-La Roche Ltd., One
Ome LLC, Empire Genomics, LLC, and Illumina, Inc.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment